Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
Northrop Grumman director Christopher W. Grady reported a compensation-related stock award. On May 20, 2026, he acquired 349 shares of Common Stock at a stated value of $552.17 per share through a grant under the Northrop Grumman 2024 Long-Term Incentive Stock Plan.
These shares were deferred into a stock unit account in a transaction exempt under Rule 16b-3. Following the award, Grady directly holds 421 shares of Northrop Grumman common stock, including amounts and dividends maintained in the stock unit account pursuant to the company’s long-term incentive plans.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Marianne Catherine Brown received a grant of 349 shares of common stock on May 20, 2026, as a compensation award. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Brown directly holds a total of 11,415 shares of Northrop Grumman common stock, including shares and dividends held in stock unit accounts under the company’s long-term incentive plans.
Northrop Grumman director David P. Abney reported an award of common stock tied to the company’s long-term incentive plan. On May 20, 2026, he acquired 349 shares of Northrop Grumman common stock at $552.17 per share in a grant classified as a compensation-related acquisition rather than an open-market purchase.
According to the filing, these 349 shares were deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this award, Abney’s directly held position is reported as 2,824 shares, consisting of 2,475 shares of common stock and 349 stock units, including dividends credited to the stock unit account.
Capital International Investors reports 7,321,667 shares (5.2%) of Northrop Grumman common stock. Amendment No. 9 to a Schedule 13G/A states CII is deemed beneficial owner of 7,321,667 shares of Common Stock (CUSIP 666807102) of Northrop Grumman Corp. as of 03/31/2026. The filing lists 7,124,472 shares subject to sole voting power and 7,321,667 shares subject to sole dispositive power, based on 141,921,621 shares believed outstanding.
Northrop Grumman director Mark A. Welsh III sold 95 shares of common stock in pre-planned transactions. On May 4, 2026, he executed 11 open-market sales at prices between $566.60 and $577.05 per share under a Rule 10b5-1 trading plan adopted on August 23, 2025. After these sales, he directly owned 4,121 Northrop Grumman shares.
Northrop Grumman Corp ownership filing shows Vanguard Capital Management beneficially owned 10,248,540 shares of Common Stock, representing 7.22% of the class as of 03/31/2026. The filing reports sole dispositive power over 10,248,540 shares and sole voting power for 1,299,313 shares. The disclosure attributes holdings to Vanguard Capital Management and specified Vanguard affiliates and notes these include securities held by Vanguard funds and managed accounts.
Northrop Grumman Corporation registered a shelf on Form S-3 to offer senior debt securities and common stock. The prospectus dated April 21, 2026 describes a shelf registration permitting sales from time to time, with specific terms and amounts to be provided in prospectus supplements.
The prospectus states proceeds will be used for general corporate purposes, including repayment of debt, share repurchases, working capital, capital expenditures and acquisitions. The filing incorporates by reference the company’s recent SEC reports and identifies The Bank of New York Mellon as indenture trustee for senior debt.
Northrop Grumman’s first quarter 2026 results show sharply higher profitability on modest sales growth. Sales rose 4% to $9.9 billion, while operating income jumped to $989 million from $573 million as operating margin expanded to 10.0% from 6.1%.
Net earnings increased 82% to $875 million and diluted EPS climbed to $6.14 from $3.32, helped by the absence of the large B‑21 loss charge recorded a year earlier and stronger segment performance, particularly in Aeronautics and Mission Systems.
Backlog remained very strong at $95.6 billion, with about 60% expected to turn into revenue within 24 months. Free cash flow was negative $1.8 billion, reflecting typical first‑half working capital usage and continued investment, including capacity expansion on the B‑21 program.
Northrop Grumman reported strong first quarter 2026 results, with sales up 4% to $9.9 billion and diluted EPS up 85% to $6.14. Net earnings rose 82% to $875 million, driven mainly by much higher operating income and pension benefits versus last year’s B‑21 loss provision.
Segment operating income nearly doubled, lifting the segment margin from 6.0% to 10.8%, led by Aeronautics Systems and Mission Systems. Space Systems saw lower sales and margins due to the NGI wind‑down and a $71 million GEM 63XL charge. Free cash flow was a use of $1.8 billion, similar to last year, reflecting typical first‑half working capital timing. The company ended the quarter with $95.6 billion of backlog and reaffirmed its 2026 guidance for sales, segment operating income, MTM‑adjusted EPS and free cash flow.